| Name | Title | Contact Details |
|---|---|---|
Vincent Balsamo |
Chief Revenue Officer | Profile |
Brandon Castel |
Vice President of Sales | Profile |
Shoshana Deutschkron |
Chief Marketing Officer | Profile |
Alex Priest |
Chief of Staff | Profile |
Freeport Health Network/Freeport Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Freeport, IL. To find more information about Freeport Health Network/Freeport Memorial Hospital, please visit www.fhn.org
From its founding in 1777 as California`s first city, San José has been a leader driven by its spirit of innovation. Today, San José stands as the largest city in Northern California and the Capital of Silicon Valley—the world`s leading center of technology innovation. San José is the 10th largest in the U.S., and is committed to remaining a top-ranked place to do business, work, live, play and learn. San José is located in Santa Clara County at the southern edge of the San Francisco Bay, about 50 miles south of San Francisco, 390 miles north of Los Angeles. The local weather is hard to beat with moderate year-round temperatures. Residents enjoy 300 days of sunshine each year and an average annual temperature of 70 degrees. The City of San José operates under the council-manager form of government, a system that combines the policy leadership of elected officials in the form of a city council, with the managerial expertise of an appointed city manager.
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Assessment Technologies Institute is a Stilwell, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Predictive Physiology and Medicine (PPM) is a Bloomington, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.